Clinical Trials Browser

Active not recruiting × apatinib × Thoracic × Clear all

NCT04379739 2023-12-06

Neoadjuvant PD-1 Antibody Plus Apatinib or Chemotherapy for Non-small Cell Lung Cancer

Phase 2 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT02493582 2016-02-05

The Study of Apatinib Plus CIK as the Third Line Therapy for Advanced Lung Adenocarcinoma Patients With Wild-Type EGFR

Phase 2 Active not recruiting

Adenocarcinoma of Lung